Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 445.01 million compared to CNY 230.87 million a year ago. Revenue was CNY 457.17 million compared to CNY 231.85 million a year ago.

Net income was CNY 101.03 million compared to CNY 46.89 million a year ago. Basic earnings per share from continuing operations was CNY 0.4454 compared to CNY 0.2067 a year ago. Diluted earnings per share from continuing operations was CNY 0.4454 compared to CNY 0.2067 a year ago.